Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,867 public trials 2,110 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer

NCT03557918

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Georgetown University Washington D.C., District of Columbia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • University of Kansas Medical Center Research Institute, Inc. Westwood, Kansas, United States
  • Dana Farber- Partners Cancer Care, Inc Boston, Massachusetts, United States
View Trial Details
Completed

A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

NCT05538572

Conditions
Adenoma, Astrocytoma, Breast Cancer, +43 more
Locations
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Celebration, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 13 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

NCT05578820

Conditions
Anus Diseases, Anus Neoplasms, Breast Diseases, +47 more
Locations
  • GBUZ Moscow Clinical Scientific Center named after Loginov MHD Moscow, Russia
  • FSBI N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia Moscow, Russia
  • FSBI National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Health of Russia Moscow, Russia
  • National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation Moscow, Russia
View Trial Details
Completed

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

NCT04641871

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell, +20 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details

Related conditions